טוען...
Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
The apparently near-term effects of the monoclonal antibody BAN2401 in slowing the progression of prodromal Alzheimer's disease (AD) has created cautious optimism about the therapeutic use of antibodies that neutralize cytotoxic soluble amyloid-β aggregates, rather than removing plaque. Plaque...
שמור ב:
| הוצא לאור ב: | Research (Wash D C) |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AAAS
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750119/ https://ncbi.nlm.nih.gov/pubmed/31549066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34133/2019/5341375 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|